FDA Inspection 1101773 — Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited — FEI 3003892973

The FDA completed an inspection of Sun Pharmaceutical Industries Limited on Aug 5, 2019 in New Delhi. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Aug 5, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New Delhi (India)

Additional Details

Clinical BA/BE

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.